{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:05:34Z","timestamp":1790694334601,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.ejphar.2009.05.013","type":"journal-article","created":{"date-parts":[[2009,5,25]],"date-time":"2009-05-25T08:07:20Z","timestamp":1243238840000},"page":"306-313","source":"Crossref","is-referenced-by-count":48,"title":["The calcimimetic AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalities in uremic rats"],"prefix":"10.1016","volume":"616","author":[{"given":"Charles","family":"Henley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Shatzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russ","family":"Cattley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Shalhoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2009.05.013_bib1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/cvr\/cvn279","article-title":"Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells","volume":"81","author":"Alam","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2009.05.013_bib2","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/jbmr.5650110714","article-title":"Direct effect of phosphorus on PTH secretion from whole rat parathyroid tissue in vitro","volume":"11","author":"Almaden","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ejphar.2009.05.013_bib3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1056\/NEJM198908033210502","article-title":"Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure","volume":"321","author":"Andress","year":"1989","journal-title":"New Eng. J. Medicine."},{"key":"10.1016\/j.ejphar.2009.05.013_bib4","series-title":"Clinical Guide to the Basics of Bone and Mineral Metabolismin CKD","first-page":"77","article-title":"Morbidity and mortality associated with abnormalities in bone and mineral metabolism in CKD","author":"Block","year":"2006"},{"key":"10.1016\/j.ejphar.2009.05.013_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium\u00d7phosphorus product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ejphar.2009.05.013_bib6","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2009.05.013_bib7","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.ki.5002059","article-title":"Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients","volume":"71","author":"Block","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2009.05.013_bib8","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","article-title":"Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis","volume":"68","author":"Block","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2009.05.013_bib9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5414\/CNP62104","article-title":"Long-term comparison of a calcium-free phosphate binder and calcium carbonate\u2013phosphorus metabolism and cardiovascular calcification","volume":"62","author":"Braun","year":"2004","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.ejphar.2009.05.013_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1152\/physrev.2001.81.1.239","article-title":"Extracellular calcium sensing and extracellular calcium signaling","volume":"81","author":"Brown","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2009.05.013_bib11","first-page":"F454","article-title":"Rat calcium-sensing receptor is regulated by vitamin D but not by calcium","volume":"270","author":"Brown","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2009.05.013_bib12","first-page":"289","article-title":"The calcium-sensing receptor: a window into the physiology and pathophysiology of mineral ion metabolism","volume":"17","author":"Chattopadhyay","year":"1996","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ejphar.2009.05.013_bib13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2009.05.013_bib14","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1681\/ASN.V115903","article-title":"Activation of the calcium receptor by a calcimimetic compound halts the progression of secondary hyperparathyroidism in uremic rats","volume":"11","author":"Chin","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2009.05.013_bib15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1523-1755.2005.67103.x","article-title":"Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism","volume":"67","author":"Colloton","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2009.05.013_bib16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/ndt\/gfg017","article-title":"Effects of calcitriol on parathyroid function and on bone remodeling in secondary hyperparathyroidism","volume":"18","author":"Costa","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejphar.2009.05.013_bib17","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1046\/j.1523-1755.2001.00042.x","article-title":"p21WAF1 and TGF-mediate parathyroid growth arrest by vitamin D and high calcium","volume":"60","author":"Cozzolino","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2009.05.013_bib18","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","article-title":"Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism","volume":"68","author":"Cunningham","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2009.05.013_bib19","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.clinthera.2004.12.011","article-title":"Secondary hyperparathyroidism: review of the disease and its treatment","volume":"26","author":"de Francisco","year":"2004","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejphar.2009.05.013_bib20","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/ndt\/gfm177","article-title":"Can calcimimetics inhibit parathyroid hyperplasia? Evidence from preclinical studies","volume":"22","author":"Drueke","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejphar.2009.05.013_bib21","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0022-3565(24)34925-0","article-title":"Calcimimetic compound NPS R-568 stimulates calcitonin secretion but selectively targets parathyroid gland Ca2+ receptor in rats","volume":"290","author":"Fox","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2009.05.013_bib22","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1053\/j.ajkd.2003.12.005","article-title":"Vascular calcification in chronic kidney disease","volume":"43","author":"Goodman","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ejphar.2009.05.013_bib23","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/sj.ki.5002287","article-title":"Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics","volume":"74","author":"Goodman","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2009.05.013_bib24","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev.med.57.121304.131328","article-title":"Therapeutic use of calcimimetics","volume":"57","author":"Hebert","year":"2006","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejphar.2009.05.013_bib25","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/ndt\/gfh834","article-title":"1,25-Dihydroxyvitamin D3 but not cinacalcet HCl treatment mediates aortic mineralization in a rat model of secondary hyperparathyroidism","volume":"20","author":"Henley","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejphar.2009.05.013_bib26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/ng1295-389","article-title":"A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism","volume":"11","author":"Ho","year":"1995","journal-title":"Nat.Genet."},{"key":"10.1016\/j.ejphar.2009.05.013_bib27","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","article-title":"Phosphate regulation of vascular smooth muscle cell calcification","volume":"87","author":"Jono","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2009.05.013_bib28","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2009.05.013_bib29","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/ki.2008.407","article-title":"Cinacalcet suppresses calcification of the aorta and heart in uremic rats","volume":"74","author":"Kawata","year":"2008","journal-title":"Kidney Int."},{"issue":"Suppl","key":"10.1016\/j.ejphar.2009.05.013_bib30","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1111\/j.1523-1755.2005.09428.x","article-title":"Calcification and cardiovascular problems in renal failure","volume":"94","author":"Ketteler","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2009.05.013_bib31","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/ki.2008.490","article-title":"A calcimimetic (R-568), but not calcitriol, prevents vascular remodeling in uremia","volume":"75","author":"Koleganova","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2009.05.013_bib32","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1210\/en.139.10.4391","article-title":"Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets and osteomalacia, but not alopecia in vitamin D receptor-ablated mice","volume":"139","author":"Li","year":"1998","journal-title":"Endocrinology."},{"key":"10.1016\/j.ejphar.2009.05.013_bib33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/ndt\/gfh829","article-title":"Effects of cinacalcet on bone mineral density in patients with secondary hyperparathyroidism","volume":"20","author":"Lien","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejphar.2009.05.013_bib34","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/01.mnh.0000168336.67499.c0","article-title":"Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia","volume":"14","author":"London","year":"2005","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.ejphar.2009.05.013_bib35","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1681\/ASN.2005040342","article-title":"Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with calcitriol","volume":"17","author":"Lopez","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2009.05.013_bib36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.ki.5002675","article-title":"The effect of calcitriol, paricalcitol and a calcimimetic on extraosseous calcifications in uremic rats","volume":"73","author":"Lopez","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2009.05.013_bib37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s10157-003-0260-0","article-title":"Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis","volume":"8","author":"Matsuoka","year":"2004","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.ejphar.2009.05.013_bib38","first-page":"698A","article-title":"Calcimimetic reduces aortic calcification in calcitriol-treated uremic rats","volume":"17","author":"Miller","year":"2006","journal-title":"Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.ejphar.2009.05.013_bib39","first-page":"iv30","article-title":"Inhibition of parathyroid gland hyperplasia and increased expression of p21 in the parathyroid are reversed upon discontinuation of cinacalcet HCl treatment","volume":"21","author":"Miller","year":"2006","journal-title":"Nephrol, Dial. Transplant."},{"key":"10.1016\/j.ejphar.2009.05.013_bib40","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1097\/01.ASN.0000141016.20133.33","article-title":"Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency","volume":"15","author":"Mizobuchi","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2009.05.013_bib41","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/jpet.103.057273","article-title":"Pharmacodynamics of the type II calcimimetics compound, cinacalcet HCl","volume":"308","author":"Nemeth","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2009.05.013_bib42","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/sj.ki.5002412","article-title":"The fallacy of the calcium\u2013phosphorous product","volume":"72","author":"O'Neill","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2009.05.013_bib43","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000188716","article-title":"Studies in a hemodialysis patient indicating that calcitriol may have a direct suppressive effect on bone","volume":"71","author":"Pahl","year":"1995","journal-title":"Nephron"},{"key":"10.1016\/j.ejphar.2009.05.013_bib44","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ejphar.2009.05.013_bib45","doi-asserted-by":"crossref","first-page":"F748","DOI":"10.1152\/ajprenal.00220.2007","article-title":"Calcimimetic R-568 or calcitriol: equally beneficial on progression of renal damage in subtotally nephrectomized rats","volume":"294","author":"Piecha","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ejphar.2009.05.013_bib46","doi-asserted-by":"crossref","first-page":"F1390","DOI":"10.1152\/ajprenal.00262.2006","article-title":"The calcimimetic R-568 increases vitamin D receptor expression in rat parathyroid glands","volume":"292","author":"Rodr\u00edguez","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ejphar.2009.05.013_bib47","doi-asserted-by":"crossref","first-page":"F253","DOI":"10.1152\/ajprenal.00302.2004","article-title":"The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism","volume":"288","author":"Rodriguez","year":"2005","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.ejphar.2009.05.013_bib48","first-page":"S483","article-title":"Pharmacological comparison of bovine parathyroid, human parathyroid, and rat kidney calcium receptors expressed in HEK 293 cells","volume":"10","author":"Rogers","year":"1995","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ejphar.2009.05.013_bib49","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00223-006-0126-z","article-title":"Calcification inhibitors and Wnt signaling proteins are implicated in bovine artery smooth muscle cell calcification in the presence of phosphate and vitamin D sterols","volume":"79","author":"Shalhoub","year":"2006","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.ejphar.2009.05.013_bib50","series-title":"Effects of Calcitriol and Paricalcitol on Gene Expression Patterns in Human Coronary Artery Smooth Muscle Cells","author":"Shalhoub","year":"2006"},{"key":"10.1016\/j.ejphar.2009.05.013_bib51","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI118701","article-title":"Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro","volume":"97","author":"Slatopolsky","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2009.05.013_bib52","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI111639","article-title":"Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients","volume":"74","author":"Slatopolsky","year":"1984","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2009.05.013_bib53","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ki.1989.89","article-title":"1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia","volume":"35","author":"Szabo","year":"1989","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2009.05.013_bib54","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/ndt\/gfi273","article-title":"Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia","volume":"21","author":"Tamagaki","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejphar.2009.05.013_bib55","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/sj.ki.5001868","article-title":"Mortality risk among hemodialysis patients receiving different vitamin D analogs","volume":"70","author":"Tentori","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2009.05.013_bib56","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/01.ATV.0000059406.92165.31","article-title":"Osteo\/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification","volume":"23","author":"Tyson","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2009.05.013_bib57","first-page":"2977","article-title":"The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency","volume":"15","author":"Wada","year":"1997","journal-title":"Control of parathyroid cell growth via a calcium receptor. J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2009.05.013_bib58","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1523-1755.1998.00782.x","article-title":"NPS R-568 halts or reverses osteitis fibrosa in uremic rats","volume":"53","author":"Wada","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2009.05.013_bib59","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1046\/j.1523-1755.2000.00837.x","article-title":"Calcimimetic NPS R-568 prevents parathyroid hyperplasia in rats with severe secondary hyperparathyroidism","volume":"57","author":"Wada","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2009.05.013_bib60","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000183992","article-title":"Animal model of adenine-induced chronic renal failure in rats","volume":"44","author":"Yokozawa","year":"1986","journal-title":"Nephron"},{"issue":"3","key":"10.1016\/j.ejphar.2009.05.013_bib61","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","article-title":"Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study","volume":"67","author":"Young","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2009.05.013_bib62","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1210\/jc.2007-2211","article-title":"Massive soft tissue calcification and cinacalcet","volume":"93","author":"Zerbi","year":"2008","journal-title":"J. Clin. Endo. Metab."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299909004944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299909004944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T17:56:13Z","timestamp":1739123773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299909004944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":62,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0014299909004944"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2009.05.013","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}